234 related articles for article (PubMed ID: 20111058)
21. Mosaic KCNJ2 mutation in Andersen-Tawil syndrome: targeted deep sequencing is useful for the detection of mosaicism.
Hasegawa K; Ohno S; Kimura H; Itoh H; Makiyama T; Yoshida Y; Horie M
Clin Genet; 2015 Mar; 87(3):279-83. PubMed ID: 24635491
[TBL] [Abstract][Full Text] [Related]
22. Biophysical and molecular characterization of a novel de novo KCNJ2 mutation associated with Andersen-Tawil syndrome and catecholaminergic polymorphic ventricular tachycardia mimicry.
Barajas-Martinez H; Hu D; Ontiveros G; Caceres G; Desai M; Burashnikov E; Scaglione J; Antzelevitch C
Circ Cardiovasc Genet; 2011 Feb; 4(1):51-7. PubMed ID: 21148745
[TBL] [Abstract][Full Text] [Related]
23. Corticosteroid-exacerbated symptoms in an Andersen's syndrome kindred.
Bendahhou S; Fournier E; Gallet S; Ménard D; Larroque MM; Barhanin J
Hum Mol Genet; 2007 Apr; 16(8):900-6. PubMed ID: 17324964
[TBL] [Abstract][Full Text] [Related]
24. Andersen-Tawil syndrome: clinical and molecular aspects.
Nguyen HL; Pieper GH; Wilders R
Int J Cardiol; 2013 Dec; 170(1):1-16. PubMed ID: 24383070
[TBL] [Abstract][Full Text] [Related]
25. Loss-of-function mutations of the K(+) channel gene KCNJ2 constitute a rare cause of long QT syndrome.
Fodstad H; Swan H; Auberson M; Gautschi I; Loffing J; Schild L; Kontula K
J Mol Cell Cardiol; 2004 Aug; 37(2):593-602. PubMed ID: 15276028
[TBL] [Abstract][Full Text] [Related]
26. [A new type of periodic paralysis: Andersen-Tawil syndrome].
Pouget J
Bull Acad Natl Med; 2008 Nov; 192(8):1551-6; discussion 1556-7. PubMed ID: 19445372
[TBL] [Abstract][Full Text] [Related]
27. Functional and clinical characterization of a mutation in KCNJ2 associated with Andersen-Tawil syndrome.
Lu CW; Lin JH; Rajawat YS; Jerng H; Rami TG; Sanchez X; DeFreitas G; Carabello B; DeMayo F; Kearney DL; Miller G; Li H; Pfaffinger PJ; Bowles NE; Khoury DS; Towbin JA
J Med Genet; 2006 Aug; 43(8):653-9. PubMed ID: 16571646
[TBL] [Abstract][Full Text] [Related]
28. Andersen-Tawil syndrome with early fixed myopathy.
Lefter S; Hardiman O; Costigan D; Lynch B; McConville J; Hand CK; Ryan AM
J Clin Neuromuscul Dis; 2014 Dec; 16(2):79-82. PubMed ID: 25415519
[TBL] [Abstract][Full Text] [Related]
29. Identification of the KCNJ2 Mutation in a Korean Family with Andersen-Tawil Syndrome and Developmental Delay.
Kim NR; Jang JH; Jeon GW; Cho EH; Sin JB
Ann Clin Lab Sci; 2016; 46(1):110-3. PubMed ID: 26927354
[TBL] [Abstract][Full Text] [Related]
30. Characterization of a novel KCNJ2 sequence variant detected in Andersen-Tawil syndrome patients.
Scheiper S; Hertel B; Beckmann BM; Kääb S; Thiel G; Kauferstein S
BMC Med Genet; 2017 Oct; 18(1):113. PubMed ID: 29017447
[TBL] [Abstract][Full Text] [Related]
31. Andersen-Tawil syndrome: prospective cohort analysis and expansion of the phenotype.
Yoon G; Oberoi S; Tristani-Firouzi M; Etheridge SP; Quitania L; Kramer JH; Miller BL; Fu YH; Ptácek LJ
Am J Med Genet A; 2006 Feb; 140(4):312-21. PubMed ID: 16419128
[TBL] [Abstract][Full Text] [Related]
32. Cardiac characteristics and long-term outcome in Andersen-Tawil syndrome patients related to KCNJ2 mutation.
Delannoy E; Sacher F; Maury P; Mabo P; Mansourati J; Magnin I; Camous JP; Tournant G; Rendu E; Kyndt F; Haïssaguerre M; Bézieau S; Guyomarch B; Le Marec H; Fressart V; Denjoy I; Probst V
Europace; 2013 Dec; 15(12):1805-11. PubMed ID: 23867365
[TBL] [Abstract][Full Text] [Related]
33. Phenotypic Variability of Andersen-Tawil Syndrome Due to Allelic Mutation c.652C>T in the
Onore ME; Picillo E; D'Ambrosio P; Morra S; Nigro V; Politano L
Biomolecules; 2024 Apr; 14(4):. PubMed ID: 38672523
[TBL] [Abstract][Full Text] [Related]
34. Kir 2.1 channelopathies: the Andersen-Tawil syndrome.
Tristani-Firouzi M; Etheridge SP
Pflugers Arch; 2010 Jul; 460(2):289-94. PubMed ID: 20306271
[TBL] [Abstract][Full Text] [Related]
35. PIP2 binding residues of Kir2.1 are common targets of mutations causing Andersen syndrome.
Donaldson MR; Jensen JL; Tristani-Firouzi M; Tawil R; Bendahhou S; Suarez WA; Cobo AM; Poza JJ; Behr E; Wagstaff J; Szepetowski P; Pereira S; Mozaffar T; Escolar DM; Fu YH; Ptácek LJ
Neurology; 2003 Jun; 60(11):1811-6. PubMed ID: 12796536
[TBL] [Abstract][Full Text] [Related]
36. Novel mutation in the KCNJ2 gene is associated with a malignant arrhythmic phenotype of Andersen-Tawil syndrome.
Fernlund E; Lundin C; Hertervig E; Kongstad O; Alders M; Platonov P
Ann Noninvasive Electrocardiol; 2013 Sep; 18(5):471-8. PubMed ID: 24047492
[TBL] [Abstract][Full Text] [Related]
37. Compound heterozygous mutations in
Polyak ME; Shestak A; Podolyak D; Zaklyazminskaya E
BMJ Case Rep; 2020 Aug; 13(8):. PubMed ID: 32843460
[TBL] [Abstract][Full Text] [Related]
38. KCNJ2 mutations in arrhythmia patients referred for LQT testing: a mutation T305A with novel effect on rectification properties.
Eckhardt LL; Farley AL; Rodriguez E; Ruwaldt K; Hammill D; Tester DJ; Ackerman MJ; Makielski JC
Heart Rhythm; 2007 Mar; 4(3):323-9. PubMed ID: 17341397
[TBL] [Abstract][Full Text] [Related]
39. KCNJ2 variant of unknown significance reclassified as long QT syndrome causing ventricular fibrillation.
Obeyesekere MN; Klein GJ; Conacher S; Krahn AD
Can J Cardiol; 2011; 27(6):870.e11-3. PubMed ID: 21875779
[TBL] [Abstract][Full Text] [Related]
40. Management and treatment of Andersen-Tawil syndrome (ATS).
Sansone V; Tawil R
Neurotherapeutics; 2007 Apr; 4(2):233-7. PubMed ID: 17395133
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
